Aesthetic medical international holdings group ltd. announces receipt of decision from the nasdaq hearings panel for conditional continued listing

Shenzhen, china, april 25, 2024 (globe newswire) -- aesthetic medical international holdings group limited (nasdaq: aih) (the “company” or “aih”), a leading provider of aesthetic medical services in china, today announced that it has received the decision of the hearings panel (the “panel”) of the nasdaq capital market (the “nasdaq”) advising the company that the panel determined to permit the continued listing of the company's securities on the nasdaq, subject to certain conditions, which include (i) on or before may 15, 2024, the company shall obtain its board approval to conduct a reverse stock split at a 10-for-1 ratio; and (ii) on or before september 3, 2024, the company shall demonstrate compliance with listing rule 5550(a)(2) (the “minimum bid price rule”) and all applicable requirements for continued listing on the nasdaq.
AIH Ratings Summary
AIH Quant Ranking